KIDS vs. EYE, LMAT, CNMD, LQDA, ENOV, AORT, CDRE, NVCR, SSII, and ESTA
Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include National Vision (EYE), LeMaitre Vascular (LMAT), CONMED (CNMD), Liquidia Technologies (LQDA), Enovis (ENOV), Artivion (AORT), Cadre (CDRE), NovoCure (NVCR), SS Innovations International (SSII), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.
OrthoPediatrics vs. Its Competitors
National Vision (NASDAQ:EYE) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.
National Vision has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.
National Vision has higher revenue and earnings than OrthoPediatrics. National Vision is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.
National Vision presently has a consensus price target of $24.73, suggesting a potential upside of 8.85%. OrthoPediatrics has a consensus price target of $34.14, suggesting a potential upside of 76.59%. Given OrthoPediatrics' stronger consensus rating and higher possible upside, analysts plainly believe OrthoPediatrics is more favorable than National Vision.
69.1% of OrthoPediatrics shares are owned by institutional investors. 2.7% of National Vision shares are owned by insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
National Vision has a net margin of -0.75% compared to OrthoPediatrics' net margin of -18.92%. National Vision's return on equity of 3.56% beat OrthoPediatrics' return on equity.
In the previous week, National Vision had 4 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for National Vision and 3 mentions for OrthoPediatrics. National Vision's average media sentiment score of 0.87 beat OrthoPediatrics' score of 0.15 indicating that National Vision is being referred to more favorably in the media.
Summary
National Vision beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks.
Get OrthoPediatrics News Delivered to You Automatically
Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OrthoPediatrics Competitors List
Related Companies and Tools
This page (NASDAQ:KIDS) was last updated on 8/15/2025 by MarketBeat.com Staff
MarketBeat All Access